BCL2 and ovarian serous tumor: Presented results in this study can suggest that aggressiveness in serous ovarian tumors (for the first time in OV7 cells) in addition to proliferation, could be linked also to apoptosis-related constituents; specifically, CAPE dysregulated BAX/BCL2 balance activating BAX gene expression level 10 times higher than BCL2.